Good Health is Your Greatest Wealth……Virgil
The FDA issued warning letters to seven manufacturers that were marketing over-the-counter hCG products, labeled has a "homeopathic" means of weight loss. In a news release, the FDA wrote that these manufacturers were, "violating federal law by selling …
See all stories on this topic »
The Food and Drug Administration has rejected a petition from environmentalists that would have banned the plastic-hardening chemical bisphenol-A from all food and drink packaging, including plastic bottles and canned food.
If green coffee bean extract were a weight–loss medication seeking FDA approval, the results would make it a viable candidate. But as a dietary supplement, it does not require the FDA's blessing; it is already available as a naturopathic medicine and …
See all stories on this topic »
| The Food and Drug Administration is taking testimony this week as it weighs whether to approve the diet drug Qnexa, with a decision expected in mid-April. If the FDA decides to approve the appetite suppressant, it would be the first weight–loss drug to … See all stories on this topic » |
 Sarasota Herald-Tribune |
To lose weight, some people are still buying into HCG drops and injections, which have received criticism from the FDA because they aren't proven to help people shed pounds. As part of the HCG diet, people take drops or receive injections of a hormone …
See all stories on this topic »
The federal government next month may give a diet drug that it once rejected for its side effects a shot at becoming that magic pill. But whether the new drug, called Qnexa, can perform weight loss wizardry depends on your definition of the word "magic …
See all stories on this topic »
The moment a dietary supplement label claims that it will treat, control, prevent or mitigate an ailment – it is making a drug claim. Health Claims Health claims are acceptable if there is “significant scientific agreement.
See all stories on this topic »
A panel of cancer experts has backed the benefits of a GlaxoSmithKline drug for a rare type of tumor, noting there are few other treatment options.
WASHINGTON (Reuters) – A Food and Drug Administration panel on Tuesday recommended GlaxoSmithKline Plc’s Votrient for treatment of advanced soft-tissue sarcoma, a relatively rare but aggressive form of cancer. The FDA advisory committee of outside experts voted 11-2 to find that the drug’s ability to improve short-term survival without worsening symptoms in patients who receive chemotherapy outweighed adverse risks and a lack of evidence that it can extend overall survival. (Reporting by David Morgan; Editing by Lisa Von Ahn)
French pharmaceutical firm Sanofi said Friday that it will buy the US company Pluromed and push for widespread adoption of its FDA- and EU-approved cardiovascular surgery aid LeGoo.
The Food and Drug Administration has received a complaint against a company that stored adult stem cells from Texas Governor Rick Perry for use in an experimental procedure to treat his back pain.
LONDON (Reuters) – AstraZeneca said on Tuesday it was suing the Food and Administration after the U.S. regulator refused to delay the market entry later this month of generic versions of top-selling antipsychotic Seroquel. The drugmaker is seeking an injunction barring the FDA from granting final marketing approval of generic forms of the drug, whose chemical name is quetiapine, until December 2, 2012, or at least until a federal court has a chance to review the agency’s action. …